[144] Wesco International Inc. SEC Filing
Wesco International (WCC) filed a Form 144 indicating a proposed sale of 51,051 common shares through UBS Financial Services on the NYSE, with an aggregate market value of $11,506,895. The shares were acquired the prior day via a stock appreciation right (SAR) exercise and are listed for sale with an approximate sale date of 08/27/2025. The filing shows 48,662,715 shares outstanding, so the proposed sale represents about 0.105% of outstanding shares.
The filer states there were no securities sold in the past three months and includes the standard certification that no undisclosed material adverse information is known. No other financial results, forward-looking statements, or additional transaction terms are provided in the notice.
- Transparent disclosure of the SAR exercise and planned sale via UBS on the NYSE
- No sales reported in the past three months, indicating this is not part of an ongoing disposal pattern
- Sale size is small relative to total shares outstanding (approximately 0.105%)
- None.
Insights
TL;DR: Routine insider sale after SAR exercise; size is small relative to float and unlikely to move the stock materially.
The filing reports a planned disposal of 51,051 shares acquired by a SAR exercise one day earlier and to be sold via UBS on the NYSE at an aggregate value of $11,506,895. With 48,662,715 shares outstanding, the sale equals roughly 0.105% of outstanding shares, which is immaterial for most liquidity and valuation considerations. The notice also confirms no sales in the prior three months, suggesting this is an isolated transaction rather than a pattern of dispositions. Absent additional context (price timing, insider role, or a standing trading plan), this filing reads as routine compliance with Rule 144.
TL;DR: Compliance-focused disclosure showing adherence to Rule 144 for a recently exercised SAR; governance implications are minimal.
The document documents required public notice for the proposed sale and contains the standard signature representation denying possession of undisclosed material information. The acquisition via SAR exercise and immediate listing for sale is disclosed transparently. There is no indication of a 10b5-1 plan adoption date in the filing, and no prior three-month sales are reported. From a governance perspective, this meets disclosure obligations but provides limited insight into insider intent or company-level governance changes.